Status:
COMPLETED
Esophagus Imaging for Radiofrequency Ablation of Atrial Fibrillation
Lead Sponsor:
Luzerner Kantonsspital
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
As the left atrium is in close vicinity to the esophagus, radiofrequency ablation in the left atrium may damage the esophagus and create esophageal perforations and esophageal left atrial fistula. The...
Detailed Description
Percutaneous catheter ablation with circumferential pulmonary vein isolation using radiofrequency energy has become an important therapeutic option to treat atrial fibrillation over the last years. Im...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patients with atrial fibrillation undergoing radiofrequency ablation
Exclusion
Key Trial Info
Start Date :
March 1 2008
Trial Type :
INTERVENTIONAL
End Date :
May 1 2009
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00650728
Start Date
March 1 2008
End Date
May 1 2009
Last Update
June 27 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kantonsspital Luzern, Department of Cardiology
Lucerne, Canton of Lucerne, Switzerland, 6005